Skip to content
  • Home
  • Contact

Scientific Program 2024

Scientific Program 2024smuser2025-03-13T13:24:19+01:00
  • Thursday, Sep 12th

  • Friday, Sep 13th

  • Saturday, Sep 14th

  • Thursday, Sep 12th

14:30 Opening industrial exhibition
15:30 Multidisciplinary Management of Complex Disease
Chair: Michael Fischereder, Michael von Bergwelt, Ulrich Specks
15:30 Welcome and introduction
Michael Fischereder, Michael von Bergwelt, Ulrich Specks
15:45 ANCA-associated vasculitis: from pathogenesis to targeted therapy
Ulrich Specks
16:15 Pulmonary hypertension associated with myeloproliferative and kidney disease
Hilary M. DuBrock
17:00 Coffee break
17:30 Lung transplantation in patients with pulmonary hypertension
Jürgen Behr
18:00 Immunotherapy of cancer – from bench to bedside
Sebastian Kobold
18:30 Get together
21:30 End of day 1
  • Friday, Sep 13th

08:00 Opening industrial exhibition
08:30 Novel Classification in Kidney Disease Impacts Management
Chair: Sanjeev Sethi, Volker Vielhauer
08:30 Greetings from the Medical Director and Chairman of the Board
Markus M. Lerch
08:40 IgA nephropathy – how to treat in the future?
Jürgen Floege
09:10 Mapping the antigens of membranous nephropathy
Sanjeev Sethi
09:50 Management of membranous nephropathy
Fernando C. Fervenza
10:20 Coffee break
10:40 Immunotherapy – from Vision to Standard of Care
Chair: Tobias Peikert, Christine Spitzweg
10:40 Lung cancer therapy in the age of immunotherapy
Tobias Peikert
11:10 Immune-checkpoint inhibitor therapy in renal cell carcinoma
Michael Staehler
11:40 Immunotherapy for mesothelioma
Tobias Peikert
12:10 Pathology of immune-checkpoint inhibitor therapy
Mariam P. Alexander
12:40 ICU management of hemato-oncologic therapy complications
Philippe R. Bauer
13:10 Lunch
14:10 New Approaches in Complex and
Rare Renal Disease
Chair: Fernando C. Fervenza, Clemens Cohen
14:10 C3 Glomerulopathy: what is new?
Sanjeev Sethi
14:30 Lupus nephritis – current and future treatment options
Ali Duarte Garcia
15:00 Primary, secondary and genetic forms of FSGS: a clinical approach
Fernando C. Fervenza
15:30 Coffee break
16:00 Dealing with Complications of Novel Therapy
Chair: Mariam P. Alexander, Michael Fischereder
16:00 Case Session
Louise Füeßl
16:30 Renal pathology in monoclonal gammopathy
Mariam P. Alexander
17:00 Avoiding collateral damage: precision immuno-therapy for autoimmunity and cancer
Maximilian F. Konig
17:30 Critical care of immunocompromised patients
Philippe R. Bauer
18:00 Keynote Lecture:
Machine Learning in outcome-oriented medical research: hope, hype or simply a dead end?
From the Institute of Artificial Intelligence in Medicine. Speaker to be announced.
18:30 End of scientific program
19:00 Welcome Reception
“The Haderner Augustiner”
19:30 Congress Dinner
(Reception and Dinner are to be booked separately)
  • Saturday, Sep 14th

08:30 Opening industrial exhibition
09:00 Cellular Therapy Approaches
Chair: Ulrich Specks, Michael von Bergwelt
09:00 CAR-T cell therapy in hemato-oncology
Veit Bücklein
09:30 CAR-T cell therapy for autoimmune disease
Andreas Mackensen
10:00 Cell therapy in infectious disease
Tobias Feuchtinger
10:30 Coffee break
11:00 From bench to bedside
Chair: Mariam P. Alexander, Ulf Schönermarck
11:00 Case Session
Veit Bücklein
11:30 APS reclassified: understanding the new criteria
and the clinical impact
Ali Duarte Garcia
12:00 Antigen-specific therapies for anti-phospholipid syndrome
Maximilian F. Konig
12:30 Wrap up and Farewell
Michael Fischereder, Michael von Bergwelt, Ulrich Specks
12:45 Lunch
13:45 End of HONPlus Circle
  • Thursday, Sep 12th

  • Friday, Sep 13th

  • Saturday, Sep 14th

  • Thursday, Sep 12th

14:30 Opening industrial exhibition
15:30 Multidisciplinary Management
of Complex Disease
15:30 Welcome and introduction
Michael Fischereder,
Michael von Bergwelt, Ulrich Specks
15:45 ANCA-associated vasculitis:
from pathogenesis
to targeted therapy
Ulrich Specks
16:15 Pulmonary hypertension
associated with
myeloproliferative
and kidney disease
Hilary M. DuBrock
17:00 Coffee break
17:30 Lung transplantation in patients
with pulmonary hypertension
Jürgen Behr
18:00 Immunotherapy of cancer
– from bench to bedside
Sebastian Kobold
18:30 Get together
21:30 End of day 1
  • Friday, Sep 13th

08:00 Opening industrial exhibition
08:30 Immunotherapy – from Vision
to Standard of Care
08:30 Lung cancer therapy
in the age of immunotherapy
Tobias Peikert
09:00 Immune-checkpoint inhibitor
therapy in renal cell carcinoma
Michael Staehler
09:30 Immunotherapy for
mesothelioma
Tobias Peikert
10:00 Pathology of
immune-checkpoint
inhibitor therapy
Mariam P. Alexander
10:30 ICU management of
hemato-oncologic therapy
complications
Philippe R. Bauer
11:00 Coffee break
11:30 Novel Classification in Kidney
Disease Impacts Management
11:30 Mapping the antigens of
membranous nephropathy
Sanjeev Sethi
12:10 Management of membranous
nephropathy
Fernando C. Fervenza
12:40 IgA nephropathy
– same, same – or different?
Jürgen Floege
13:10 Lunch
14:10 New Approaches in Complex
and Rare Renal Disease
14:10 C3 Glomerulonephritis
– the Mayo Clinic experience
Sanjeev Sethi
14:30 Lupus nephritis
– current and future treatment
options
Ali Duarte Garcia
15:00 Primary, secondary and
genetic forms of FSGS:
a clinical approace
Fernando C. Fervenza
15:30 Coffee break
16:00 Dealing with Complications of
Novel Therapy
16:00 Case Session
16:30 Renal pathology in monoclonal
gammopathy
Mariam P. Alexander
17:00 Critical care of
immunocompromised patients
Philippe R. Bauer
17:30 Avoiding collateral damage:
precision immuno-therapy
for autoimmunity and cancer
Maximilian F. Konig
18:00 End of program
19:00 Congress Dinner
(to be booked separately)
  • Saturday, Sep 14th

08:30 Opening industrial exhibition
09:00 Cellular Therapy Approaches
09:00 CAR-T cell therapy in
hemato-oncology
Marion Subklewe
09:30 CAR-T cell therapy for
autoimmune disease
Andreas Mackensen
10:00 Cell therapy in
infectious disease
Tobias Feuchtinger
10:30 Coffee break
11:00 From bench to bedside
11:00 Case Session
11:30 APS classification and impact
Ali Duarte Garcia
12:00 Antigen-specific therapies for
anti-phospholipid syndrome
Maximilian F. Konig
12:30 Wrap up and Farewell
Michael Fischereder,
Michael von Bergwelt,
Ulrich Specks
12:45 Lunch
13:45 End of HONPlus Circle
Download full Program
  • Thursday, Sep 12th

  • Friday, Sep 13th

  • Saturday, Sep 14th

  • Thursday, Sep 12th

14:30 Opening industrial exhibition
15:30 Multidisciplinary Management of Complex Disease
15:30 Welcome and introduction
Michael Fischereder, Michael von Bergwelt, Ulrich Specks
15:45 ANCA-associated vasculitis: from pathogenesis to targeted therapy
Ulrich Specks
16:15 Pulmonary hypertension associated with myeloproliferative and kidney disease
Hilary M. DuBrock
17:00 Coffee break
17:30 Lung transplantation in patients with pulmonary hypertension
Jürgen Behr
18:00 Immunotherapy of cancer – from bench to bedside
Sebastian Kobold
18:30 Get together
21:30 End of day 1
  • Friday, Sep 13th

08:00 Opening industrial exhibition
08:30 Immunotherapy – from Vision to Standard of Care
08:30 Lung cancer therapy in the age of immunotherapy
Tobias Peikert
09:00 Immune-checkpoint inhibitor therapy in renal cell carcinoma
Michael Staehler
09:30 Immunotherapy for mesothelioma
Tobias Peikert
10:00 Pathology of immune-checkpoint inhibitor therapy
Mariam P. Alexander
10:30 ICU management of hemato-oncologic therapy complications
Philippe R. Bauer
11:00 Coffee break
11:30 Novel Classification in Kidney Disease Impacts Management
11:30 Mapping the antigens of membranous nephropathy
Sanjeev Sethi
12:10 Management of membranous nephropathy
Fernando C. Fervenza
12:40 IgA nephropathy – same, same – or different?
Jürgen Floege
13:10 Lunch
14:10 New Approaches in Complex and
Rare Renal Disease
14:10 C3 Glomerulonephritis – the Mayo Clinic experience
Sanjeev Sethi
14:30 Lupus nephritis – current and future treatment options
Ali Duarte Garcia
15:00 Primary, secondary and genetic forms of FSGS: a clinical approace
Fernando C. Fervenza
15:30 Coffee break
16:00 Dealing with Complications of Novel Therapy
16:00 Case Session
16:30 Renal pathology in monoclonal gammopathy
Mariam P. Alexander
17:00 Critical care of immunocompromised patients
Philippe R. Bauer
17:30 Avoiding collateral damage: precision immuno-therapy for autoimmunity and cancer
Maximilian F. Konig
18:00 End of program
19:00 Congress Dinner (to be booked separately)
  • Saturday, Sep 14th

08:30 Opening industrial exhibition
09:00 Cellular Therapy Approaches
09:00 CAR-T cell therapy in hemato-oncology
Marion Subklewe
09:30 CAR-T cell therapy for autoimmune disease
Andreas Mackensen
10:00 Cell therapy in infectious disease
Tobias Feuchtinger
10:30 Coffee break
11:00 From bench to bedside
11:00 Case Session
11:30 APS reclassified: understanding the new criteria
and the clinical impact
Ali Duarte Garcia
12:00 Antigen-specific therapies for anti-phospholipid syndrome
Maximilian F. Konig
12:30 Wrap up and Farewell
Michael Fischereder, Michael von Bergwelt, Ulrich Specks
12:45 Lunch
13:45 End of HONPlus Circle
  • Thursday, Sep 12th

  • Friday, Sep 13th

  • Saturday, Sep 14th

  • Thursday, Sep 12th

14:30 Opening industrial
exhibition
15:30 Multidisciplinary
Management
of Complex Disease
Chair: Michael Fischereder, Michael
von Bergwelt, Ulrich Specks
15:30 Welcome and
introduction
Michael Fischereder,
Michael von Bergwelt,
Ulrich Specks
15:45 ANCA-associated
vasculitis:
from pathogenesis
to targeted therapy
Ulrich Specks
16:15 Pulmonary hypertension
associated with
myeloproliferative
and kidney disease
Hilary M. DuBrock
17:00 Coffee break
17:30 Lung transplantation
in patients
with pulmonary
hypertension
Jürgen Behr
18:00 Immunotherapy
of cancer
– from bench to bedside
Sebastian Kobold
18:30 Get together
21:30 End of day 1
  • Friday, Sep 13th

08:00 Opening industrial
exhibition
08:30 Novel Classification
in Kidney Disease
Impacts Management
Chair: Sanjeev Sethi,
Volker Vielhauer
08:30 Greetings from the Medical
Director and Chairman
of the Board
Markus M. Lerch
08:40 IgA nephropathy – how to
treat in the future?
Jürgen Floege
09:10 Mapping the antigens of
membranous nephropathy
Sanjeev Sethi
09:50 Management of
membranous
nephropathy
Fernando C. Fervenza
10:20 Coffee break
10:40 Immunotherapy
– from Vision
to Standard of Care
Chair: Tobias Peikert,
Christine Spitzweg
10:40 Lung cancer therapy
in the age of
immunotherapy

Tobias Peikert
11:10 Immune-checkpoint
inhibitor
therapy in renal
cell carcinoma

Michael Staehler
11:40 Immunotherapy for
mesothelioma
Tobias Peikert
12:10 Pathology of
immune-checkpoint
inhibitor therapy
Mariam P. Alexander
12:40 ICU management of
hemato-oncologic
therapy
complications
Philippe R. Bauer
13:10 Lunch
14:10 New Approaches in
Complex
and Rare
Renal Disease
Chair: Fernando C. Fervenza,
Clemens Cohen
14:10 C3 Glomerulopathy:
what is new?
Sanjeev Sethi
14:30 Lupus nephritis
– current and future
treatment
options
Ali Duarte Garcia
15:00 Primary, secondary and
genetic forms of FSGS:
a clinical approace
Fernando C. Fervenza
15:30 Coffee break
16:00 Dealing with Complications
of Novel Therapy
Chair: Mariam P. Alexander,
Michael Fischereder
16:00 Case Session
16:30 Renal pathology in
monoclonal
gammopathy
Mariam P. Alexander
17:00 Avoiding collateral
damage:
precision
immuno-therapy
for autoimmunity
and cancer
Maximilian F. Konig
17:30 Critical care of
immunocompromised
patients
Philippe R. Bauer
18:00 Keynote Lecture:
Machine Learning in
outcome-oriented medical
research: hope, hype or
simply a dead end?
From the Institute of
Artificial Intelligence
in Medicine.
Speaker to be announced.
18:30 End of scientific program
19:00 Welcome Reception
“The Hardener Augustiner”
19:30 Congress Dinner
(Reception and Dinner
are to be booked separately)
  • Saturday, Sep 14th

08:30 Opening industrial
exhibition
09:00 Cellular Therapy
Approaches
Chair: Ulrich Specks,
Michael von Bergwelt
09:00 CAR-T cell therapy in
hemato-oncology
Veit Bücklein
09:30 CAR-T cell therapy for
autoimmune disease
Andreas Mackensen
10:00 Cell therapy in
infectious disease
Tobias Feuchtinger
10:30 Coffee break
11:00 From bench to bedside
Chair: Mariam P. Alexander,
Ulf Schönermarck
11:00 Case Session
11:30 APS classification
and impact
Ali Duarte Garcia
12:00 Antigen-specific
therapies for
anti-phospholipid
syndrome
Maximilian F. Konig
12:30 Wrap up and Farewell
Michael Fischereder,
Michael von Bergwelt,
Ulrich Specks
12:45 Lunch
13:45 End of HONPlus Circle
  • Privacy Policy
  • Legal notice
  • General Terms and Conditions
  • Revocation policy
  • Contact
  • Program 2024
  • Sponsorship 2024
Page load link
Go to Top